Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's CEO, Albert Bourla, reports acquiring 27 phantom stock units under the company's deferred compensation plan.

Summary

• Albert Bourla, the Chairman and CEO of Pfizer Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 15, 2025, Bourla acquired 27 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $22.6.
• Following the transaction, Bourla directly owns 719,518 shares of Pfizer common stock.
• The phantom stock units are settled in cash following Bourla's separation from service and can be transferred into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing. The acquisition of phantom stock units is generally viewed positively as it aligns management's interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The acquisition of phantom stock units aligns the CEO's interests with the long-term performance of the company.
• The deferred compensation plan allows for tax-advantaged savings.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their alignment with shareholder interests. Phantom stock units are a common form of deferred compensation used by companies to incentivize executives.

Comparison to Industry Standards

• Deferred compensation plans, including phantom stock units, are widely used among large pharmaceutical companies like Johnson & Johnson (JNJ) and Merck (MRK) to attract and retain top executive talent.
• The structure and terms of Pfizer's Nonfunded Deferred Compensation and Supplemental Savings Plan are likely comparable to those offered by its peers.

Stakeholder Impact

• The acquisition of phantom stock units by the CEO can positively impact shareholders by aligning management's interests with the company's long-term success.
• Employees may view the deferred compensation plan as a positive benefit, potentially improving morale and retention.

Key Dates

Keywords

Form 4, Pfizer, Albert Bourla, phantom stock units, beneficial ownership, deferred compensation, PFE